Dec. 30, 2013 – In the wake of the GlaxoSmithKline (GSK) decision to stop paying physicians for speaking engagements and attendance at medical conferences, a debate has been sparked over the value of these activities, according to two recent articles in Policy and Medicine. In a Dec. 17 article, Policy and Medicine wrote about GSK’s […]
Read more